Disorders in mtFASII lead to the following metabolic diseases: 
* ACSF3: Combined malonic and methylmalonic aciduria (CMAMMA)
* MCAT: Medium-chain acyl-CoA dehydrogenase deficiency (MCAD) 
* MECR: Mitochondrial enoyl-CoA reductase protein-associated neurodegeneration (MEPAN)